Abstract
In this issue of Blood, Miraki-Moud et al demonstrate that the majority of acute myeloid leukemias (AMLs) have low expression of argininosuccinate synthetase-1 (ASS1), rendering AML cell lines and primary AML blasts dependent on exogenous arginine and sensitized to arginine deprivation.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 3971-3972 |
| Number of pages | 2 |
| Journal | Blood |
| Volume | 125 |
| Issue number | 26 |
| DOIs | |
| State | Published - Jun 25 2015 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology